CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • February 5th, 2015 • Immunogen Inc • Pharmaceutical preparations • Massachusetts
This Agreement is entered into as of the 5th day of January, 2015 (the “Effective Date”) by and between ImmunoGen, Inc., a Massachusetts corporation (the “Company”), and Richard J. Gregory (the “Executive”).
AMENDMENT NO. 2 TO COLLABORATIVE DEVELOPMENT AND LICENSE AGREEMENTCollaborative Development and License Agreement • February 5th, 2015 • Immunogen Inc • Pharmaceutical preparations
This Amendment No. 2 (this “Amendment No. 2”) to the Collaborative Development and License Agreement entered into as of July 7, 2006 (the “Agreement Effective Date”), as amended as of August 23, 2006 (the “Agreement”) by and between ImmunoGen, a Massachusetts corporation with its principal place of business at 830 Winter Street, Waltham, Massachusetts 02451, USA (“ImmunoGen”) and Biotest AG, a corporation organized under the laws of Germany having an address of Landerstrasse 5, D-63303 Dreieich, Germany (“Biotest”) is dated as of December10, 2014.
